TQ05105

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for TQ05105, covering 2025-02-11 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate/High-risk Myelofibrosis [Phase 2]

See pricing